Steven J. Rice is CAO at Vir Biotechnology, Inc. (VIR). They have made 5 open-market trades across 1 company since 2021, most recently 2023-06-01.
CIK 0001820108
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VIR | 106,840 | $1.3M |
Shares reported on the most recent Form 4, priced at the 2023-06-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VIR | SELL · 10b5-1 | 2023-06-01 | 2023-06-02 | $25.67 | $128K | -3.7% | -8.9% | -53.1% |
| VIR | SELL | 2023-02-23 | 2023-02-24 | $25.97 | $47K | -0.4% | +1.1% | +13.3% |
| VIR | SELL | 2023-02-17 | 2023-02-21 | $25.29 | $100K | -15.4% | -17.6% | -4.7% |
| VIR | SELL | 2022-02-17 | 2022-02-22 | $31.93 | $124K | -21.9% | -15.1% | -18.7% |
| VIR | SELL | 2021-11-30 | 2021-12-02 | $50.00 | $500K | +0.3% | -14.1% | -47.4% |
| VIR | SELL | 2021-08-23 | 2021-08-24 | $50.00 | $500K | -1.7% | -10.3% | -36.5% |
| VIR | SELL · 10b5-1 | 2021-06-25 | 2021-06-29 | $50.00 | $150 | -19.2% | -21.9% | -3.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.